Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy A 74-year-old man taking rivaroxaban for atrial fibrillation developed a subdural hematoma and had an elevated prothrombin time (PT) with normal activated partial thromboplastin time (aPTT) and platelets prior to planned surgical evacuation. How do you interpret the results? http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy

JAMA , Volume 320 (14) – Oct 9, 2018

Loading next page...
 
/lp/american-medical-association/coagulation-test-interpretation-in-a-patient-taking-direct-oral-s4bEjna02o
Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.13998
pmid
30242329
Publisher site
See Article on Publisher Site

Abstract

A 74-year-old man taking rivaroxaban for atrial fibrillation developed a subdural hematoma and had an elevated prothrombin time (PT) with normal activated partial thromboplastin time (aPTT) and platelets prior to planned surgical evacuation. How do you interpret the results?

Journal

JAMAAmerican Medical Association

Published: Oct 9, 2018

References